RVV

COM:REVIVETHERA

Revive Therapeutics Ltd.

  • Stock

CAD

Last Close

0.01

22/11 20:58

Market Cap

3.58M

Beta: -

Volume Today

45K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
net income
-1.26M
-
-2.03M
61.57%
-2.74M
34.80%
-1.62M
40.98%
-1.79M
10.83%
-1.34M
24.96%
-5.38M
300.46%
-20.12M
273.84%
-17.81M
11.49%
-6.32M
64.50%
-5.62M
11.11%
depreciation and amortization
4.35K
-
6.59K
51.61%
6.22K
5.58%
3.57K
42.61%
3.13K
12.32%
3.20K
2.20%
28.27K
783.01%
775
97.26%
578
25.42%
434
24.91%
328
24.42%
deferred income tax
-278.41K
-
-73.99K
73.43%
-203.96K
175.67%
1.65M
-
1.56M
5.58%
stock based compensation
187.35K
-
293.60K
56.72%
115.36K
60.71%
144.28K
25.07%
195.60K
35.57%
133.23K
31.89%
1.19M
794.18%
8.57M
619.23%
1.04M
87.89%
change in working capital
-51.87K
-
222.42K
528.78%
588.42K
164.55%
-553.50K
194.07%
93.69K
116.93%
-4.85K
105.17%
-502.99K
10,275.17%
705.75K
240.31%
3.54M
401.73%
-747.61K
121.11%
-185.54K
75.18%
accounts receivables
-100.79K
-
67.51K
166.98%
-45.20K
166.96%
59.73K
232.15%
10.65K
82.17%
inventory
accounts payables
other working capital
-4.85K
-
-402.20K
8,196.16%
638.24K
258.69%
3.59M
461.88%
-807.35K
122.51%
-196.19K
75.70%
other non cash items
348.81K
-
293.60K
15.83%
115.36K
60.71%
144.28K
25.07%
27.39K
-
502.65K
1,735.49%
982.15K
95.39%
167.35K
82.96%
1.04M
522.85%
2.51M
141.09%
net cash provided by operating activities
-768.46K
-
-1.49M
94.32%
-1.99M
33.03%
-2.08M
4.77%
-1.50M
28.00%
-1.18M
20.92%
-2.52M
112.30%
-8.31M
230.22%
-13.06M
57.23%
-6.03M
53.86%
-3.29M
45.39%
investments in property plant and equipment
-31.81K
-
-38.00K
19.45%
-1.50K
96.05%
-1.51K
1%
-10.90K
619.67%
-685
93.72%
-3M
-
acquisitions net
purchases of investments
-750K
-
sales maturities of investments
142.24K
-
281.35K
97.80%
other investing activites
net cash used for investing activites
-31.81K
-
-38.00K
19.45%
-1.50K
96.05%
-1.51K
1%
-10.90K
619.67%
-750.68K
6,785.12%
142.24K
118.95%
-2.72M
2,011.31%
debt repayment
-136.18K
-
-149.00K
9.41%
-151.53K
1.70%
-152.04K
0.33%
-40K
73.69%
common stock issued
1.11M
-
3.13M
181.15%
844.69K
73.02%
1.50M
77.58%
1.35M
-
3.39M
151.27%
28.67M
744.97%
376.15K
98.69%
4.20M
1,015.92%
2.02M
51.96%
common stock repurchased
dividends paid
other financing activites
169.78K
-
-296.27K
274.50%
-15.47K
94.78%
1.02M
6,679.91%
1.35K
-
22.86K
1,593.23%
-2.28M
10,056.77%
151.73K
106.67%
152.04K
0.20%
net cash used provided by financing activities
1.28M
-
2.83M
120.87%
829.22K
70.74%
2.52M
203.68%
801.17K
68.18%
1.35M
68.54%
3.28M
142.88%
26.24M
700.21%
376.35K
98.57%
4.20M
1,015.32%
1.98M
52.91%
effect of forex changes on cash
net change in cash
483.05K
-
1.30M
169.77%
-1.16M
188.93%
435.44K
137.58%
-708.16K
262.63%
-585.28K
17.35%
906.25K
254.84%
15.22M
1,579.25%
-12.68M
183.35%
-1.83M
85.59%
-1.31M
28.11%
cash at beginning of period
705.87K
-
1.19M
68.43%
2.49M
109.61%
1.33M
46.50%
1.77M
32.66%
1.06M
40.04%
475.23K
55.19%
1.38M
190.70%
16.60M
1,101.58%
3.92M
76.41%
2.14M
45.41%
cash at end of period
1.19M
-
2.49M
109.61%
1.33M
46.50%
1.77M
32.66%
1.06M
40.04%
475.23K
55.19%
1.38M
190.70%
16.60M
1,101.58%
3.92M
76.41%
2.09M
46.69%
823.07K
60.57%
operating cash flow
-768.46K
-
-1.49M
94.32%
-1.99M
33.03%
-2.08M
4.77%
-1.50M
28.00%
-1.18M
20.92%
-2.52M
112.30%
-8.31M
230.22%
-13.06M
57.23%
-6.03M
53.86%
-3.29M
45.39%
capital expenditure
-31.81K
-
-38.00K
19.45%
-1.50K
96.05%
-1.51K
1%
-10.90K
619.67%
-685
93.72%
-3M
-
free cash flow
-800.28K
-
-1.53M
91.35%
-1.99M
29.83%
-2.08M
4.76%
-1.51M
27.53%
-1.19M
21.45%
-2.52M
112.18%
-11.31M
349.47%
-13.06M
15.51%
-6.03M
53.86%
-3.29M
45.39%

All numbers in CAD (except ratios and percentages)